REPORT ID 6753

Global Prostate Cancer Medicine Market Research Report 2017

Publish Date
1-Nov-17
Pages
104
Format
Electronic (PDF)

In this report, the global Prostate Cancer Medicine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Prostate Cancer Medicine in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Prostate Cancer Medicine market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    AstraZeneca plc
    Active Biotech
    Bristol Myers-Squibb
    Teva Pharmaceuticals Industries Ltd.
    Johnson & Johnson
    Pfizer Inc.
    Bayer AG
    Abbott Laboratories
    Astellas Pharma Inc.
    Roche Holding AG
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Hormonal Therapy Drugs
    Chemotherapy Drugs
    Immunotherapy Drugs
    Target Therapy Drugs
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Prostate Cancer Medicine for each application, including
    Hospital
    Pharmacy
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Prostate Cancer Medicine Market Research Report 2017
1 Prostate Cancer Medicine Market Overview
    1.1 Product Overview and Scope of Prostate Cancer Medicine
    1.2 Prostate Cancer Medicine Segment by Type (Product Category)
        1.2.1 Global Prostate Cancer Medicine Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Prostate Cancer Medicine Production Market Share by Type (Product Category) in 2016
        1.2.3 Hormonal Therapy Drugs
        1.2.4 Chemotherapy Drugs
        1.2.5 Immunotherapy Drugs
        1.2.6 Target Therapy Drugs
    1.3 Global Prostate Cancer Medicine Segment by Application
        1.3.1 Prostate Cancer Medicine Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Hospital
        1.3.3 Pharmacy
        1.3.4 Others
    1.4 Global Prostate Cancer Medicine Market by Region (2012-2022)
        1.4.1 Global Prostate Cancer Medicine Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Prostate Cancer Medicine (2012-2022)
        1.5.1 Global Prostate Cancer Medicine Revenue Status and Outlook (2012-2022)
        1.5.2 Global Prostate Cancer Medicine Capacity, Production Status and Outlook (2012-2022)

2 Global Prostate Cancer Medicine Market Competition by Manufacturers
    2.1 Global Prostate Cancer Medicine Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Prostate Cancer Medicine Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Prostate Cancer Medicine Production and Share by Manufacturers (2012-2017)
    2.2 Global Prostate Cancer Medicine Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Prostate Cancer Medicine Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Prostate Cancer Medicine Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Prostate Cancer Medicine Market Competitive Situation and Trends
        2.5.1 Prostate Cancer Medicine Market Concentration Rate
        2.5.2 Prostate Cancer Medicine Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Prostate Cancer Medicine Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Prostate Cancer Medicine Capacity and Market Share by Region (2012-2017)
    3.2 Global Prostate Cancer Medicine Production and Market Share by Region (2012-2017)
    3.3 Global Prostate Cancer Medicine Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Prostate Cancer Medicine Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Prostate Cancer Medicine Consumption by Region (2012-2017)
    4.2 North America Prostate Cancer Medicine Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Prostate Cancer Medicine Production, Consumption, Export, Import (2012-2017)
    4.4 China Prostate Cancer Medicine Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Prostate Cancer Medicine Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Prostate Cancer Medicine Production, Consumption, Export, Import (2012-2017)
    4.7 India Prostate Cancer Medicine Production, Consumption, Export, Import (2012-2017)

5 Global Prostate Cancer Medicine Production, Revenue (Value), Price Trend by Type
    5.1 Global Prostate Cancer Medicine Production and Market Share by Type (2012-2017)
    5.2 Global Prostate Cancer Medicine Revenue and Market Share by Type (2012-2017)
    5.3 Global Prostate Cancer Medicine Price by Type (2012-2017)
    5.4 Global Prostate Cancer Medicine Production Growth by Type (2012-2017)

6 Global Prostate Cancer Medicine Market Analysis by Application
    6.1 Global Prostate Cancer Medicine Consumption and Market Share by Application (2012-2017)
    6.2 Global Prostate Cancer Medicine Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Prostate Cancer Medicine Manufacturers Profiles/Analysis
    7.1 AstraZeneca plc
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Prostate Cancer Medicine Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 AstraZeneca plc Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Active Biotech
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Prostate Cancer Medicine Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Active Biotech Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Bristol Myers-Squibb
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Prostate Cancer Medicine Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Bristol Myers-Squibb Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Teva Pharmaceuticals Industries Ltd.
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Prostate Cancer Medicine Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Johnson & Johnson
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Prostate Cancer Medicine Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Johnson & Johnson Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Pfizer Inc.
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Prostate Cancer Medicine Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Pfizer Inc. Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Bayer AG
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Prostate Cancer Medicine Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Bayer AG Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Abbott Laboratories
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Prostate Cancer Medicine Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Abbott Laboratories Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Astellas Pharma Inc.
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Prostate Cancer Medicine Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Astellas Pharma Inc. Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Roche Holding AG
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Prostate Cancer Medicine Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Roche Holding AG Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview

8 Prostate Cancer Medicine Manufacturing Cost Analysis
    8.1 Prostate Cancer Medicine Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Prostate Cancer Medicine

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Prostate Cancer Medicine Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Prostate Cancer Medicine Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Prostate Cancer Medicine Market Forecast (2017-2022)
    12.1 Global Prostate Cancer Medicine Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Prostate Cancer Medicine Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Prostate Cancer Medicine Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Prostate Cancer Medicine Price and Trend Forecast (2017-2022)
    12.2 Global Prostate Cancer Medicine Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Prostate Cancer Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Prostate Cancer Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Prostate Cancer Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Prostate Cancer Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Prostate Cancer Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Prostate Cancer Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Prostate Cancer Medicine Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Prostate Cancer Medicine Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer